At the gene expression level, GEPIA analysis of the PAAD cancer dataset revealed a significant 95% increase in relative EFR3A mRNA level in pancreatic adenocarcinoma tumors (n = 179) compared to matched normal (n = 171) tissues (Fig. 1d). This evidence concerns the gene EFR3A and pancreatic adenocarcinoma.